Actuate Therapeutics ACTU
NASDAQ ACTU
$0.48 -0.04 (-7.69%)
At close: Oct 23, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Cash & Current Investments (2024 - 2026)

Updated

Actuate Therapeutics' Cash & Current Investments was $4.43 million in Q2 2026, down 31.8% from $6.49 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) Cash & Current Investments (2024 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Actuate Therapeutics came in at $13.16 million, up 52.3% from FY2024.

  • In earlier years, Cash & Current Investments was $8.64 million in FY2024.
  • The Q2 2026 figure marks the lowest quarterly Cash & Current Investments since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Actuate Therapeutics 11.53 Mn -29.48 Mn - 4.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.43 Mn
Dec 31, 2025 13.16 Mn
Sep 30, 2025 16.92 Mn
Jun 30, 2025 6.49 Mn
Mar 31, 2025 3.89 Mn
Dec 31, 2024 8.64 Mn
Sep 30, 2024 13.52 Mn
Jun 30, 2024 351,709.00
API Access

Actuate Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ACTU&period=max&api_key=YOUR_API_KEY